Patents by Inventor Christoph Hagemeyer

Christoph Hagemeyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSION PROTEINS
    Publication number: 20240100134
    Abstract: The present invention relates to chimeric and fusion proteins and their compositions, and the use of such proteins and compositions in the prevention and/or treatment diseases or conditions requiring plasminogen supplementation. In one aspect, the invention provides a chimeric or fusion protein comprising plasminogen and an Fc region of an antibody.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 28, 2024
    Applicant: Monash University
    Inventors: James C. Whisstock, Ruby HP Law, Adam J. Quek, Christoph Hagemeyer, Mikael Martino, Guojie Wu, Yen-Zhen Lu
  • ANTI-VWF ANTIBODIES AND USES THEREOF
    Publication number: 20230227580
    Abstract: The invention also relates to antigen binding proteins and related fragments thereof for binding Von Willebrand factor (VWF) and uses thereof. In one aspect, the present invention provides an antigen binding protein comprising an antigen binding domain that binds to or specifically binds to Von Willebrand factor (VWF) under shear gradient conditions. Preferably, the antigen binding protein comprises an antigen binding domain that does not bind to VWF under constant shear conditions.
    Type: Application
    Filed: June 25, 2021
    Publication date: July 20, 2023
    Applicants: MONASH UNIVERSITY, BAKER HEART AND DIABETES INSTITUTE
    Inventors: Christoph HAGEMEYER, Erik WESTEIN, Thomas HOEFER, Robert ANDREWS, Elizabeth GARDINER
  • Polylysine dendrimer contrast agent
    Patent number: 9127130
    Abstract: The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogs, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: September 8, 2015
    Assignees: STARPHARMA PTY LTD., BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LTD
    Inventors: Guy Yeoman Krippner, Zemin Wu, Karlheinz Peter, Christoph Hagemeyer, David Owen
  • POLYLYSINE DENDRIMER CONTRAST AGENT
    Publication number: 20100278750
    Abstract: The present invention relates generally to branched macromolecules and their use as imaging or contrast agents. In particular, the invention relates to dendrimers, derived from lysine or lysine analogues, bearing a plurality of functional moieties and their application to imaging techniques in which a disease state may be imaged with a targeted contrast agent.
    Type: Application
    Filed: August 10, 2007
    Publication date: November 4, 2010
    Applicants: STARPHARMA PTY LTD, BAKER MEDICAL RESEARCH INSTITUTE
    Inventors: Guy Yeoman Krippner, Zemin Wu, Karlheinz Peter, Christoph Hagemeyer, David Owen